SMBA1 is a highly potent Bax agonist with antitumor activity that induces cell cycle arrest and apoptosis in malignant glioma cells. SMBA1 can be used to study triple-negative breast cancer.
Molecular Weight:
315.32
Purity:
98.91%
CAS Number:
[906440-37-7]
Formula:
C20H13NO3
Target:
Bcl-2 Family
T8792
* VAT and and shipping costs not included. Errors and price changes excepted